Scientists in laboratory working on research

Finding Solutions

Respond to adverse regulatory inspection findings, build a compliant quality system and avoid future problems with a custom remediation plan.

Wherever you are in the product lifecycle, NSF provides solutions and expert guidance. Conduct rescue trials, respond to adverse regulatory inspection findings, build a compliant pharmaceutical quality system or create effective corrective and preventive actions (CAPAs) as part of your remediation plan.

How Can We Help?

Remediation

Receive expert guidance in product development, market application, manufacturing, distribution and continuous monitoring of your medical devices, IVDs and combination products.

Recall Strategy

Optimize your recall strategy by using NSF experts to identify gaps in your processes against industry best practices.

Post-Inspection and Post-Market Response

Draft and submit regulatory responses and reports with the assistance of our highly experienced, global regulatory experts.

Resources

1 of

News and Events

NSF Now Offering Live Instructor-Led Virtual Pharmaceutical and Medical Devices Training

May 19, 2020

To complement its face-to-face offering, NSF now offers traditional classroom courses as virtual instructor-led training to support your professional development. Courses are delivered via a combination of live instructor-led virtual classrooms and self-paced online learning. NSF’s coaches are on hand to guide participants through the interactive sessions which also include pre- and post-course activities.

NSF Health Sciences Podcasts – Access Expert Content On-the-Go

October 22, 2020

Access a wealth of free podcasts and webinar recordings from our pharma and medical devices experts to help you make better business decisions and stay up to date with the latest industry trends.

NSF International’s Health Sciences Team Joins Fight to Save Lives With More Ventilators

April 23, 2020

NSF International’s health sciences team is hands-on in the rapid ventilator manufacturing specification issued by the United Kingdom (UK) government. The UK National Health Service needs thousands more ventilators to help save lives as the country’s COVID-19 pandemic approaches its expected peak and ventilator capacity becomes a challenge.

Amarex, an NSF International Company, Executes Five Rush COVID-19 Related Submissions to the FDA

April 2, 2020

Submissions include an IND, IND Amendment and Compassionate Use Approval for CytoDyn’s product Leronlimab, a Compassionate Use Approval for a treatment device, and an EUA for a PCR-based IVD for COVID-19 detection

See More News